We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWI
676
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
$737K 0.02%
+19,476
New +$680K
DAR icon
677
Darling Ingredients
DAR
$9.44B
$735K 0.02%
+35,174
New +$752K
DNKN
678
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$735K 0.02%
15,242
+426
+3% +$20.2K
SHW icon
679
Sherwin-Williams
SHW
$89.8B
$734K 0.02%
11,994
-273
-2% -$16.7K
MR
680
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$734K 0.02%
20,180
+4,742
+31% +$184K
A icon
681
Agilent Technologies
A
$41.2B
$732K 0.02%
17,889
-1,046
-6% -$39.8K
MAA icon
682
Mid-America Apartment Communities
MAA
$15.7B
$732K 0.02%
+12,060
New +$754K
IMOS
683
ChipMOS TECHNOLOGIES
IMOS
$1.83B
$731K 0.02%
34,486
ARMH
684
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$730K 0.02%
13,342
+8,989
+207% +$438K
FTSL icon
685
First Trust Senior Loan Fund ETF
FTSL
$2.33B
$729K 0.02%
14,687
+1,071
+8% +$53K
KW
686
DELISTED
Kennedy-Wilson Holdings
KW
$728K 0.02%
32,700
-2,000
-6% -$40.2K
NOBL icon
687
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$720K 0.02%
+32,624
New +$700K
PHYS icon
688
Sprott Physical Gold
PHYS
$15.7B
$720K 0.02%
72,200
-8,750
-11% -$92.2K
LKQ icon
689
LKQ Corp
LKQ
$6.29B
$719K 0.02%
+21,855
New +$713K
RDS.B
690
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$719K 0.02%
9,577
-2,251
-19% -$158K
ARRS
691
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$718K 0.02%
+29,500
New +$563K
PLL
692
DELISTED
PALL CORP
PLL
$715K 0.02%
8,379
+4,954
+145% +$403K
MYGN icon
693
Myriad Genetics
MYGN
$312M
$713K 0.02%
33,988
+24,413
+255% +$617K
PII icon
694
Polaris
PII
$4.07B
$710K 0.02%
4,880
+110
+2% +$14.7K
IFLN
695
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
$707K 0.02%
36,848
+17,349
+89% +$332K
GVI icon
696
iShares Intermediate Government/Credit Bond ETF
GVI
$3.8B
$704K 0.02%
6,434
DWAS icon
697
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$450M
$703K 0.02%
17,721
+9,922
+127% +$376K
TAYC
698
DELISTED
TAYLOR CAPITAL GROUP INC
TAYC
$701K 0.02%
+26,356
New +$629K
EWT icon
699
iShares MSCI Taiwan ETF
EWT
$11.1B
$696K 0.02%
24,115
+166
+0.7% +$4.73K
ISRG icon
700
Intuitive Surgical
ISRG
$134B
$695K 0.02%
16,281
-8,208
-34% -$345K

Similar funds

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.